# Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study

> **NCT04496362** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Baylor Research Institute** · enrollment: 100 (estimated)

## Conditions studied

- ECMO
- Heparin
- Respiratory Failure

## Interventions

- **DRUG:** subcutaneous heparin anticoagulation

## Key facts

- **NCT ID:** NCT04496362
- **Lead sponsor:** Baylor Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-10-10
- **Primary completion:** 2025-02-12
- **Final completion:** 2026-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04496362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04496362, "Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT04496362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*